Form 4: Edwards Lifesciences Executive Sells Shares
Insider Transaction (Form 4)
Daniel J. Lippis, CVP, TAVR of Edwards Lifesciences Corp, sold 619 shares of common stock on August 11, 2026 for $92.03 per share.
Summary
- Option exercise/conversion: acquired 619 Common Stock at $72.68 ($44,989) on August 11, 2026; holds 40,653 after (Direct).
- Open-market sale: disposed of 619 Common Stock at $92.03 ($56,967) on August 11, 2026; holds 40,034 after (Direct).
- Option exercise/conversion: disposed of 619 Employee Stock Option (Right to Acquire) on August 11, 2026; holds 4,333 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $56,967 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Daniel J. Lippis — Officer (CVP, TAVR)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-11 | Option exercise/conversion | Common Stock | 619 | $73 | $45.0K | 40,652.91 |
| 2026-08-11 | Open-market sale | Common Stock | 619 | $92 | $57.0K | 40,033.91 |
| 2026-08-11 | Option exercise/conversion | Employee Stock Option (Right to Acquire) | 619 | — | — | 4,333 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-11 | Option exercise/conversion (619 shares) |
| 2026-08-11 | Open-market sale (619 shares) |
| 2026-08-11 | Option exercise/conversion (619 shares) |
Keywords
insider transaction, Form 4, EW, Edwards Lifesciences Corp, bearish, Daniel J. Lippis
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.